Search

Your search keyword '"Bierzynska A"' showing total 209 results

Search Constraints

Start Over You searched for: Author "Bierzynska A" Remove constraint Author: "Bierzynska A"
209 results on '"Bierzynska A"'

Search Results

2. Rare heterozygous variants in paediatric steroid resistant nephrotic syndrome – a population-based analysis of their significance

4. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis.

5. Exploring the relevance of NUP93 variants in steroid-resistant nephrotic syndrome using next generation sequencing and a fly kidney model

6. Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

7. A critical re-analysis of cases of post-transplantation recurrence in genetic nephrotic syndrome

8. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

9. National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study.

10. Investigating the genotype-phenotype correlations in paediatric steroid resistant nephrotic syndrome patients

11. A role for OCRL in glomerular function and disease

12. Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria(European Journal of Human Genetics, (2021), 29, 8, (1186-1197), 10.1038/s41431-021-00858-1)

13. Whole-genome sequencing of patients with rare diseases in a national health system.

15. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption

16. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management

17. Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances

18. No Risk, No Differences. Neural Correlates of Temperamental Traits Revealed Using Naturalistic fMRI Method

19. FAT1 mutations cause a glomerulotubular nephropathy

20. Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome

21. Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

22. Correction: Guidelines for Genetic Testing and Management of Alport Syndrome

23. Shared genetic risk across different presentations of gene test–negative idiopathic nephrotic syndrome

24. Recent advances in understanding and treating nephrotic syndrome [version 1; referees: 2 approved]

25. Exploring the relevance of NUP93 variants in steroid-resistant nephrotic syndrome using next generation sequencing and a fly kidney model

26. GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements

27. Shared genetic risk across different presentations of gene test-negative idiopathic nephrotic syndrome

28. Guidelines for genetic testing and management of Alport syndrome

29. A Rare Autosomal Dominant Variant in Regulator of Calcineurin Type 1 (RCAN1) Gene Confers Enhanced Calcineurin Activity and May Cause FSGS

30. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis

32. Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease

34. Response to First Course of Intensified Immunosuppression in Genetically Stratified Steroid Resistant Nephrotic Syndrome

35. CYTOKINESIS-BLOCK MICRONUCLEUS ASSAY IN HUMAN GLIOMA CELLS EXPOSED TO RADIATION

36. Guidelines for Genetic Testing and Management of Alport Syndrome

37. Podocyte Bioenergetics in the Development of Diabetic Nephropathy: The Role of Mitochondria

39. Guidelines for Genetic Testing and Management of Alport Syndrome

40. Whole-genome sequencing of patients with rare diseases in a national health system

41. TBC1D8B Loss-of-Function Mutations Lead to X-Linked Nephrotic Syndrome via Defective Trafficking Pathways

42. A Rare Autosomal Dominant Variant in Regulator of Calcineurin Type 1 (RCAN1) Gene Confers Enhanced Calcineurin Activity and May Cause FSGS

43. Bayesian Inference Associates Rare KDR Variants with Specific Phenotypes in Pulmonary Arterial Hypertension

44. A Rare Autosomal Dominant Variant in Regulator of Calcineurin Type 1 (

45. Publisher Correction:Whole-genome sequencing of a sporadic primary immunodeficiency cohort (Nature, (2020), 583, 7814, (90-95), 10.1038/s41586-020-2265-1)

46. MO075DNA METHYLATION AND RESPONSE TO STEROIDS IN CHILDREN WITH NEPHROTIC SYNDROME

47. Whole-genome sequencing of a sporadic primary immunodeficiency cohort

48. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

49. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis

Catalog

Books, media, physical & digital resources